The evolution of risk factors for respiratory syncytial virus-related hospitalisation in infants born at 32-35 weeks' gestational age: time-based analysis using data from the FLIP-2 study

被引:13
|
作者
Carbonell, Xavier [1 ]
Fullarton, John R. [2 ]
Gooch, Katherine L. [3 ]
Figueras-Aloy, Jose [4 ]
机构
[1] Hosp Clin Barcelona, Serv Neonatol, Barcelona, Spain
[2] Strategen Ltd, Basingstoke, Hants, England
[3] Abbott Labs, Chicago, IL USA
[4] Hosp Clin Seu Maternitat, Serv Neonatol, Barcelona, Spain
关键词
Infant; patient admission; premature; respiratory syncytial viruses; risk factors; INFECTION REQUIRING HOSPITALIZATION; 35 COMPLETED WEEKS; PREMATURE-INFANTS; BRONCHIOLITIS; ASTHMA; ALLERGY; MORBIDITY; CHILDREN; WHEEZE;
D O I
10.1515/jpm-2011-0248
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Aim: The aim of this study was to examine whether the risk for respiratory syncytial virus (RSV)-related hospitalisation changes through the first year of life in infants of 32-35 weeks' gestational age (wGA). Methods: Risk factors from the FLIP-2 study (190 cases/4566 age-matched controls) were included in a Cox regression analysis wherein time slices were taken at 1-month intervals from birth. Results: Half of all RSV hospitalisations occurred in the first 68 days after birth, with 56% occurring within 90 days. The time taken for 50% of hospitalisations to occur was 148 days for those born outside the RSV season and 58 days for those born within the season. By 90 days old, 84% of infants born in the season and 20% of those born outside the season were hospitalised. In both groups, hospitalisations occurred >= 5 months after birth. Male sex, smoking whilst pregnant, month of birth, duration of breastfeeding, number of siblings at school, and number of smokers in household all contributed to the risk of RSV hospitalisation beyond the age of 90 days. Conclusions: The risk of RSV hospitalisation appears to persist to at least 5-6 months old in 32-35 wGA infants, which has implications for the optimal management of disease prevention.
引用
收藏
页码:685 / 691
页数:7
相关论文
共 18 条
  • [1] FLIP-2 study -: Risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks
    Figueras-Aloy, Jose
    Carbonell-Estrany, Xavier
    Quero-Jimenez, Jose
    Fernandez-Colomer, Belen
    Guzman-Cabanas, Juana
    Echaniz-Urcelay, Innaqui
    Domenech-Martinez, Eduardo
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (09) : 788 - 793
  • [2] Burden of respiratory syncytial virus hospitalisation among infants born at 32-35 weeks' gestational age in the Northern Hemisphere: pooled analysis of seven studies
    Lanari, M.
    Anderson, E. J.
    Sheridan-Pereira, M.
    Carbonell-Estrany, X.
    Paes, B.
    Rodgers-Gray, B. S.
    Fullarton, J. R.
    Grubb, E.
    Blanken, M.
    [J]. EPIDEMIOLOGY AND INFECTION, 2020, 148
  • [3] A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33–35 weeks of gestational age, based on data from the Spanish FLIP study
    Eric AF Simões
    Xavier Carbonell-Estrany
    John R Fullarton
    Johannes G Liese
    Jose Figueras-Aloy
    Gunther Doering
    Juana Guzman
    [J]. Respiratory Research, 9
  • [4] A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP study
    Simoes, Eric A. F.
    Carbonell-Estrany, Xavier
    Fullarton, John R.
    Liese, Johannes G.
    Figueras-Aloy, Jose
    Doering, Gunther
    Guzman, Juana
    [J]. RESPIRATORY RESEARCH, 2008, 9 (1):
  • [5] Insurance Status and the Risk of Severe Respiratory Syncytial Virus Disease in United States Preterm Infants Born at 32-35 Weeks Gestational Age
    Franklin, Jeremy A.
    Anderson, Evan J.
    Wu, Xionghua
    Ambrose, Christopher S.
    Simoes, Eric A. F.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (03):
  • [6] The risk of respiratory syncytial virus-related hospitalizations in preterm infants of 29 to 35 weeks' gestational age
    Doering, Gunther
    Gusenleitner, Walter
    Belohradsky, Bernd H.
    Burdach, Stefan
    Resch, Bernhard
    Liese, Johannes G.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (12) : 1188 - 1190
  • [7] Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32-35 weeks' gestational age with more informed use of risk factors?
    Carbonell-Estrany, Xavier
    Fullarton, John R.
    Rodgers-Gray, Barry S.
    Gooch, Katherine L.
    Vo, Pamela G.
    Figueras-Aloy, Jose
    [J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2015, 28 (10): : 1133 - 1141
  • [8] The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32-35 weeks: a Canadian-based analysis
    Lanctot, Krista L.
    Masoud, Shababa T.
    Paes, Bosco A.
    Tarride, Jean-Eric
    Chiu, Aaron
    Hui, Charles
    Francis, Philip L.
    Oh, Paul I.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (11) : 3223 - 3237
  • [9] ASSESSMENT OF THE COST-EFFECTIVENESS OF RISK FACTOR GUIDED PROPHYLAXIS WITH PALIVIZUMAB FOR THE PREVENTION OF SEVERE RESPIRATORY SYNCYTIAL VIRUS INFECTION IN COLOMBIAN INFANTS BORN AT 32-35 WEEKS' GESTATIONAL AGE
    Rodriguez-Martinez, C. E.
    Ordonez, J.
    Carbonell-Estrany, X.
    Fullarton, J.
    Keary, I
    Rodgers-Gray, B.
    D'Apremont, I
    Espinosa, S. M.
    Ribeiro, P. A.
    Stein, R.
    Vain, N.
    Tarride, J. E.
    Paes, B.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S156 - S156
  • [10] OPTIMIZING THE USE OF RISK FACTORS TO GUIDE THE COST-EFFECTIVE USE OF PALIVIZUMAB PROPHYLAXIS AGAINST SEVERE RESPIRATORY SYNCYTIAL VIRUS INFECTION IN KOREAN INFANTS BORN 32-35 WEEKS' GESTATIONAL AGE
    Keary, I
    Kang, J. M.
    Paes, B.
    Rodgers-Gray, B.
    Fullarton, J.
    Tarride, J. E.
    Yang, H. J.
    Chang, Y. S.
    Carbonell-Estrany, X.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S125 - S125